However, many ANO1 inhibitors, including T16Ainh-A01, N-(4-methoxy-2-naphthyl)-5-nitroanthranilic acid (MONNA), and idebenone (52–54), show limited efficacy and poor selectivity for asthma treatment. The gene discussed is ANO1; the disease is asthma.